1 treatment center
No centers match
Try a different search term
1 SAMHSA-listed treatment center in Greeley, Colorado. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Free, confidential assistance matching you with the right program in Greeley.
Greeley, Colorado has 1 SAMHSA-verified addiction treatment center offering 1 dual diagnosis, 1 outpatient. Each facility listed here is verified through the Substance Abuse and Mental Health Services Administration (SAMHSA) and provides evidence-based treatment approaches.
Outpatient programs allow Greeley residents to receive treatment while maintaining their daily responsibilities. Sessions are typically scheduled 3-5 days per week, making it possible to continue working or attending school.
Treatment centers in Greeley accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Overdose response in Greeley: signs of opioid overdose include slowed or stopped breathing, blue lips or fingertips, pinpoint pupils, unconsciousness, and limp body. If you suspect overdose, call 911 immediately, administer naloxone (Narcan nasal spray is most common), perform rescue breathing or CPR if trained, and stay with the person until paramedics arrive. Colorado Good Samaritan laws generally protect callers from prosecution for drug-related offenses when seeking emergency help, with specific protections varying by state.
Patients searching for treatment in Greeley often face decision fatigue: dozens of facilities advertise similar services, success-rate claims are unverifiable, and insurance-coverage details are opaque until the verification call. The pragmatic approach is to screen along a few specific criteria — licensing status, accepted insurance, ASAM-aligned clinical assessment, dual-diagnosis capacity, family involvement, and aftercare planning — rather than to rely on marketing claims or reviews. Each of the Greeley providers listed has been screened against these criteria before inclusion.
Attention-deficit/hyperactivity disorder (ADHD) in Greeley treatment patients raises specific clinical questions: ADHD medication continuation (stimulant medications can be appropriate even in addiction-recovery contexts but require careful prescribing), evaluation of whether substance use was self-medication for untreated ADHD, and behavioral interventions for executive-function deficits that complicate early-recovery tasks like appointment-keeping, financial management, and structured-day adherence. Adult ADHD remains under-diagnosed in addiction-treatment populations.
Pre-authorization is the most common insurance friction for Greeley patients entering residential addiction treatment. Insurers require clinical documentation that ASAM criteria for residential placement are met — specifically that lower-intensity outpatient care has been tried or is clinically insufficient, and that the patient's withdrawal risk, co-occurring conditions, or environmental factors require 24-hour structure. Treatment-provider clinical staff handle this documentation; patients can typically expect 24-48 hour authorization turnaround.
Sober living environments (SLEs) in Greeley and surrounding areas bridge residential treatment and full independent living. SLE quality varies considerably; the National Alliance for Recovery Residences (NARR) provides a certification framework with four quality levels (peer-run to clinically integrated). Reputable Greeley-area SLEs require drug testing, mutual-support meeting attendance, progressive responsibility (employment, household contribution), and structured-day adherence. Typical stay length is 3-12 months, longer for patients with severe addiction histories.
Same-day or rapid admission to Greeley programs is most often possible at facilities with rolling intake capacity, particularly during weekday business hours. Weekend admissions are increasingly common but require advance arrangement. Emergency department presentation with active overdose or severe withdrawal sometimes serves as a bridge to Greeley treatment entry — hospital case managers can coordinate transfer to residential treatment directly from ED, particularly for patients with insurance that covers acute stabilization plus subsequent residential.
Medication-assisted treatment (MAT) for opioid use disorder is available in Greeley through multiple pathways: federally certified Opioid Treatment Programs (OTPs) dispensing methadone, office-based buprenorphine prescribers (now expanded after the X-waiver elimination), and extended-release naltrexone (Vivitrol) at clinics willing to administer the monthly injection. Each medication has clinical use cases — methadone for severe long-standing opioid use disorder, buprenorphine for outpatient maintenance, naltrexone for patients fully detoxed and committed to abstinence-based recovery.